The Tumor Cytosol miRNAs, Fluid miRNAs and Exosome miRNAs in Lung Cancer
The focus of this review is to provide an update on the progress of microRNAs (miRNAs) as potential biomarkers for lung cancer. miRNAs are single-stranded, small noncoding RNAs that regulate gene expression and show tissue-specific signatures. Accumulating evidence indicates that miRNA expression pa...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2015-01-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | http://journal.frontiersin.org/Journal/10.3389/fonc.2014.00357/full |
| _version_ | 1828521711545352192 |
|---|---|
| author | Xin eQin Haisheng eXu Wenrong eGong Wenbin eDeng Wenbin eDeng |
| author_facet | Xin eQin Haisheng eXu Wenrong eGong Wenbin eDeng Wenbin eDeng |
| author_sort | Xin eQin |
| collection | DOAJ |
| description | The focus of this review is to provide an update on the progress of microRNAs (miRNAs) as potential biomarkers for lung cancer. miRNAs are single-stranded, small noncoding RNAs that regulate gene expression and show tissue-specific signatures. Accumulating evidence indicates that miRNA expression patterns represent the in vivo status in physiology and disease. Moreover, miRNAs are stable in serum and other clinically convenient and available tissue sources, so they are being developed as biomarkers for cancer and other diseases. Cancer is currently the primary driver of the field, but miRNA biomarkers are being developed for many other diseases such as cardiovascular and central nervous system diseases. Here we examine the framework and scope of the miRNA landscape as it specifically relates to the translation of miRNA expression patterns/signatures into biomarkers for developing diagnostics for lung cancer. We focus on examining tumor cytosol miRNAs, fluid miRNAs, and exosome miRNAs in lung cancer, the connections among these miRNAs, and the potential of miRNA biomarkers for the development of diagnostics. In lung cancer, miRNAs have been studied in both cell populations and in the circulation. However, a major challenge is to develop biomarkers to monitor cancer development and to identify circulating miRNAs that are linked to cancer stage. Importantly, the fact that miRNAs can be successfully harvested from biological fluids allows for the development of biofluid biopsies, in which miRNAs as circulating biomarkers can be captured and analyzed ex vivo. Our hope is that these minimally invasive entities provide a window to the in vivo milieu of the patients without the need for costly, complex invasive procedures, rapidly moving miRNAs from research to the clinic. |
| first_indexed | 2024-12-11T19:53:48Z |
| format | Article |
| id | doaj.art-591f63a9debd49368e7158498245179e |
| institution | Directory Open Access Journal |
| issn | 2234-943X |
| language | English |
| last_indexed | 2024-12-11T19:53:48Z |
| publishDate | 2015-01-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Oncology |
| spelling | doaj.art-591f63a9debd49368e7158498245179e2022-12-22T00:52:42ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2015-01-01410.3389/fonc.2014.00357127346The Tumor Cytosol miRNAs, Fluid miRNAs and Exosome miRNAs in Lung CancerXin eQin0Haisheng eXu1Wenrong eGong2Wenbin eDeng3Wenbin eDeng4Hubei University of Arts and ScienceXiangyang Central HospitalHubei University of Arts and ScienceUniversity of California, DavisHubei University of Arts and ScienceThe focus of this review is to provide an update on the progress of microRNAs (miRNAs) as potential biomarkers for lung cancer. miRNAs are single-stranded, small noncoding RNAs that regulate gene expression and show tissue-specific signatures. Accumulating evidence indicates that miRNA expression patterns represent the in vivo status in physiology and disease. Moreover, miRNAs are stable in serum and other clinically convenient and available tissue sources, so they are being developed as biomarkers for cancer and other diseases. Cancer is currently the primary driver of the field, but miRNA biomarkers are being developed for many other diseases such as cardiovascular and central nervous system diseases. Here we examine the framework and scope of the miRNA landscape as it specifically relates to the translation of miRNA expression patterns/signatures into biomarkers for developing diagnostics for lung cancer. We focus on examining tumor cytosol miRNAs, fluid miRNAs, and exosome miRNAs in lung cancer, the connections among these miRNAs, and the potential of miRNA biomarkers for the development of diagnostics. In lung cancer, miRNAs have been studied in both cell populations and in the circulation. However, a major challenge is to develop biomarkers to monitor cancer development and to identify circulating miRNAs that are linked to cancer stage. Importantly, the fact that miRNAs can be successfully harvested from biological fluids allows for the development of biofluid biopsies, in which miRNAs as circulating biomarkers can be captured and analyzed ex vivo. Our hope is that these minimally invasive entities provide a window to the in vivo milieu of the patients without the need for costly, complex invasive procedures, rapidly moving miRNAs from research to the clinic.http://journal.frontiersin.org/Journal/10.3389/fonc.2014.00357/fullExosomesmicroRNAlung cancerbiomarkersTumor Cytosol |
| spellingShingle | Xin eQin Haisheng eXu Wenrong eGong Wenbin eDeng Wenbin eDeng The Tumor Cytosol miRNAs, Fluid miRNAs and Exosome miRNAs in Lung Cancer Frontiers in Oncology Exosomes microRNA lung cancer biomarkers Tumor Cytosol |
| title | The Tumor Cytosol miRNAs, Fluid miRNAs and Exosome miRNAs in Lung Cancer |
| title_full | The Tumor Cytosol miRNAs, Fluid miRNAs and Exosome miRNAs in Lung Cancer |
| title_fullStr | The Tumor Cytosol miRNAs, Fluid miRNAs and Exosome miRNAs in Lung Cancer |
| title_full_unstemmed | The Tumor Cytosol miRNAs, Fluid miRNAs and Exosome miRNAs in Lung Cancer |
| title_short | The Tumor Cytosol miRNAs, Fluid miRNAs and Exosome miRNAs in Lung Cancer |
| title_sort | tumor cytosol mirnas fluid mirnas and exosome mirnas in lung cancer |
| topic | Exosomes microRNA lung cancer biomarkers Tumor Cytosol |
| url | http://journal.frontiersin.org/Journal/10.3389/fonc.2014.00357/full |
| work_keys_str_mv | AT xineqin thetumorcytosolmirnasfluidmirnasandexosomemirnasinlungcancer AT haishengexu thetumorcytosolmirnasfluidmirnasandexosomemirnasinlungcancer AT wenrongegong thetumorcytosolmirnasfluidmirnasandexosomemirnasinlungcancer AT wenbinedeng thetumorcytosolmirnasfluidmirnasandexosomemirnasinlungcancer AT wenbinedeng thetumorcytosolmirnasfluidmirnasandexosomemirnasinlungcancer AT xineqin tumorcytosolmirnasfluidmirnasandexosomemirnasinlungcancer AT haishengexu tumorcytosolmirnasfluidmirnasandexosomemirnasinlungcancer AT wenrongegong tumorcytosolmirnasfluidmirnasandexosomemirnasinlungcancer AT wenbinedeng tumorcytosolmirnasfluidmirnasandexosomemirnasinlungcancer AT wenbinedeng tumorcytosolmirnasfluidmirnasandexosomemirnasinlungcancer |